NEWAMSTERDAM PHARMA COMPANY

Ticker: NAMS CUSIP: N62509109 Class: Stock

ADAGE CAPITAL PARTNERS GP, L.L.C.'s Holding History (CIK: 0001165408)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 1,406,631 Value ($000) $49,345 Avg Close $36.39 Range $28.19 - $42.00
Q3 2025
Shares 2,576,631 Value ($000) $73,279 Avg Close $23.97 Range $17.97 - $28.91
Q2 2025
Shares 3,013,009 Value ($000) $54,566 Avg Close $18.24 Range $14.06 - $22.25
Q1 2025
Shares 1,950,650 Value ($000) $39,930 Avg Close $22.23 Range $17.18 - $26.80
Q4 2024
Shares 1,050,000 Value ($000) $26,985 Avg Close $21.24 Range $15.51 - $27.29
Q3 2024
Shares 1,380,000 Value ($000) $22,908 Avg Close $17.30 Range $15.19 - $21.48
Q2 2024
Shares 1,530,000 Value ($000) $29,391 Avg Close $20.06 Range $16.62 - $24.79
Q1 2024
Shares 1,824,601 Value ($000) $43,152 Avg Close $20.30 Range $11.18 - $26.35
Q4 2023
Shares 1,300,000 Value ($000) $14,521 Avg Close $9.16 Range $5.63 - $11.89
Q3 2023
Shares 1,200,000 Value ($000) $11,100 Avg Close $10.83 Range $8.57 - $12.54
Q2 2023
Shares 1,200,000 Value ($000) $14,268 Avg Close $13.27 Range $11.03 - $17.00